Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin in Active Microscopic Colitis
NCT04043897Phase 2Recruiting
- Start
- Jun 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifaximin in microscopic colitis (MC). Started Jun 2018; status: recruiting.
02
Drugs
rifaximin
03
Conditions
microscopic colitis (MC)
Beyond the preview
Go deeper on NCT04043897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04043897.